
Kernal Bio Partners with Lilly Gateway Labs to Boost In Vivo Cell Therapy Development
Kernal Biologics Joins Lilly Gateway Labs to Accelerate In Vivo Cell Therapy Programs Kernal Biologics, Inc., a venture-backed biotechnology company pioneering transformative therapeutics to program human cells directly inside the body, has announced its official relocation to Lilly Gateway Labs…













